Acute Kidney Injury Global Market Report 2025

Description

Acute kidney injury (AKI) is characterized by a sudden decline in kidney function, resulting in the buildup of waste products, electrolytes, and fluids within the body. It can develop within hours or days and is commonly triggered by factors such as reduced blood flow, direct kidney damage, or urinary tract obstruction.

The primary types of acute kidney injury include pre-renal, post-renal, and intrinsic kidney injury. Pre-renal kidney injury occurs due to a significant reduction in blood flow to the kidneys, leading to impaired filtration. Treatment options include dialysis, drug therapy, and urinary implants, serving end users such as hospitals, ambulatory surgical centers, and other healthcare facilities.

The acute kidney injury market research report is one of a series of new reports from The Business Research Company that provides acute kidney injury market statistics, including acute kidney injury industry global market size, regional shares, competitors with an acute kidney injury market share, detailed acute kidney injury market segments, market trends and opportunities, and any further data you may need to thrive in the acute kidney injury industry. This acute kidney injury market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acute kidney injury market size has grown strongly in recent years. It will grow from $5.37 billion in 2024 to $5.74 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, growing incidence of hospital-acquired infections, increasing awareness about kidney health, and advancements in critical care medicine.

The acute kidney injury market size is expected to see strong growth in the next few years. It will grow to $7.39 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The projected growth during the forecast period is driven by the increasing incidence of sepsis, rising demand for personalized treatment, expanding government healthcare initiatives, growing healthcare expenditure in emerging markets, and a strong emphasis on personalized medicine and regenerative therapies. Key trends expected during this period include the development of wearable dialysis devices, the integration of artificial intelligence for treatment optimization, advancements in portable renal replacement therapy systems, innovations in continuous renal replacement therapy (CRRT), and the expansion of remote monitoring and telemedicine solutions.

The increasing prevalence of diabetes is expected to drive the expansion of the acute kidney injury (AKI) market. Diabetes encompasses a group of metabolic diseases characterized by elevated blood sugar levels, either due to insufficient insulin production or the body's inability to use insulin effectively. The rising incidence of diabetes is attributed to factors such as increasing obesity rates, poor dietary habits, sedentary lifestyles, aging populations, and improved awareness and diagnostic capabilities. Acute kidney injury induces metabolic and inflammatory changes that can impact insulin resistance and glucose regulation, creating a complex relationship that may affect diabetes management and progression. For example, in March 2024, the Office for Health Improvement & Disparities, a UK-based government department, reported that between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, while for type 2 diabetes, it increased by 21%. Additionally, the proportion of individuals achieving target HbA1c levels reached 37.9%, marking the highest figure ever recorded by the National Diabetes Audit (NDA). Consequently, the rising prevalence of diabetes is fueling the growth of the acute kidney injury market.

Leading companies in the acute kidney injury (AKI) market are prioritizing regulatory approvals to expand their product offerings and introduce novel treatment solutions. Regulatory approvals, granted by bodies such as the FDA or EMA, confirm that a product meets stringent safety, efficacy, and quality standards before entering the market. For instance, in December 2023, Mission Therapeutics Ltd., a UK-based biotechnology company, received FDA approval to initiate a Phase II clinical trial for its lead asset, MTX652, targeting acute kidney injury in high-risk patients following cardiac surgery. MTX652 is designed to target key pathways involved in kidney injury and repair, with the goal of reducing inflammation, preventing further kidney damage, and promoting recovery. A distinctive aspect of this trial is its focus on novel therapeutic mechanisms that address the molecular causes of AKI, potentially offering more effective treatment options compared to current interventions. The Phase II trial will assess MTX652's safety, efficacy, and pharmacokinetics, generating critical data that could support broader clinical use and eventual regulatory approval.

In July 2022, Terumo Blood and Cell Technologies, a US-based medical equipment manufacturer, partnered with Eliaz Therapeutics Inc. to develop an innovative therapeutic apheresis treatment for acute kidney injury (AKI) and sepsis-induced AKI (S-AKI). This treatment is designed to selectively remove the inflammatory protein Galectin-3 from blood plasma, with the objective of improving patient outcomes, reducing the risk of chronic kidney disease, and lowering hospital mortality rates. Eliaz Therapeutics Inc. is a US-based developer of medical devices specializing in innovative treatments for AKI and S-AKI.

Major players in the acute kidney injury market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Medical Co. Ltd., Teva Pharmaceutical Industries Ltd., Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, Nikkiso Co. Ltd., Quark Pharmaceuticals Inc., Kringle Pharma Inc., Aptabio Therapeutics Inc., Alexion Pharmaceuticals Inc., Alloksys Life Sciences B.V., AM-Pharma B.V., Arch Biopartners Inc., Guard Therapeutics International AB.

North America was the largest region in the acute kidney injury market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in acute kidney injury report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the acute kidney injury market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The acute kidney injury market includes revenues earned by entities by providing services such as urinalysis & biomarker testing, imaging services, dialysis services, and surgical & interventional procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acute Kidney Injury Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acute kidney injury market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acute kidney injury ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acute kidney injury market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Injury: Pre-Renal Kidney Injury; Post-Renal Kidney Injury; Intrinsic Kidney Injury
2) By Treatment Type: Dialysis; Drug Therapy; Urinary Implants
3) By End User: Hospitals; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Pre-Renal Kidney Injury: Hypovolemia; Heart Failure-Related Injury; Sepsis-Induced Injury; Renal Artery Stenosis; Hepatorenal Syndrome
2) By Post-Renal Kidney Injury: Ureteral Obstruction; Bladder Outlet Obstruction; Prostate Enlargement (Benign Prostatic Hyperplasia); Kidney Stones; Tumors Affecting Urinary Tract
3) By Intrinsic Kidney Injury: Acute Tubular Necrosis (ATN); Acute Interstitial Nephritis (AIN); Glomerulonephritis; Vasculitis; Rhabdomyolysis-Induced Injury
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd; Merck & Co. Inc.; Sanofi S.A.; Bristol-Myers Squibb Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33945

1. Executive Summary

2. Acute Kidney Injury Market Characteristics

3. Acute Kidney Injury Market Trends And Strategies

4. Acute Kidney Injury Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Acute Kidney Injury Growth Analysis And Strategic Analysis Framework

5.1. Global Acute Kidney Injury PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Acute Kidney Injury Market Growth Rate Analysis
5.4. Global Acute Kidney Injury Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Acute Kidney Injury Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Acute Kidney Injury Total Addressable Market (TAM)

6. Acute Kidney Injury Market Segmentation

6.1. Global Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pre-Renal Kidney Injury
Post-Renal Kidney Injury
Intrinsic Kidney Injury
6.2. Global Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dialysis
Drug Therapy
Urinary Implants
6.3. Global Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Ambulatory Surgical Centers
Other End Users
6.4. Global Acute Kidney Injury Market, Sub-Segmentation Of Pre-Renal Kidney Injury, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hypovolemia
Heart Failure-Related Injury
Sepsis-Induced Injury
Renal Artery Stenosis
Hepatorenal Syndrome
6.5. Global Acute Kidney Injury Market, Sub-Segmentation Of Post-Renal Kidney Injury, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ureteral Obstruction
Bladder Outlet Obstruction
Prostate Enlargement (Benign Prostatic Hyperplasia)
Kidney Stones
Tumors Affecting Urinary Tract
6.6. Global Acute Kidney Injury Market, Sub-Segmentation Of Intrinsic Kidney Injury, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acute Tubular Necrosis (ATN)
Acute Interstitial Nephritis (AIN)
Glomerulonephritis
Vasculitis
Rhabdomyolysis-Induced Injury

7. Acute Kidney Injury Market Regional And Country Analysis

7.1. Global Acute Kidney Injury Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Acute Kidney Injury Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Acute Kidney Injury Market

8.1. Asia-Pacific Acute Kidney Injury Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Acute Kidney Injury Market

9.1. China Acute Kidney Injury Market Overview
9.2. China Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Acute Kidney Injury Market

10.1. India Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Acute Kidney Injury Market

11.1. Japan Acute Kidney Injury Market Overview
11.2. Japan Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Acute Kidney Injury Market

12.1. Australia Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Acute Kidney Injury Market

13.1. Indonesia Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Acute Kidney Injury Market

14.1. South Korea Acute Kidney Injury Market Overview
14.2. South Korea Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Acute Kidney Injury Market

15.1. Western Europe Acute Kidney Injury Market Overview
15.2. Western Europe Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Acute Kidney Injury Market

16.1. UK Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Acute Kidney Injury Market

17.1. Germany Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Acute Kidney Injury Market

18.1. France Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Acute Kidney Injury Market

19.1. Italy Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Acute Kidney Injury Market

20.1. Spain Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Acute Kidney Injury Market

21.1. Eastern Europe Acute Kidney Injury Market Overview
21.2. Eastern Europe Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Acute Kidney Injury Market

22.1. Russia Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Acute Kidney Injury Market

23.1. North America Acute Kidney Injury Market Overview
23.2. North America Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Acute Kidney Injury Market

24.1. USA Acute Kidney Injury Market Overview
24.2. USA Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Acute Kidney Injury Market

25.1. Canada Acute Kidney Injury Market Overview
25.2. Canada Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Acute Kidney Injury Market

26.1. South America Acute Kidney Injury Market Overview
26.2. South America Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Acute Kidney Injury Market

27.1. Brazil Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Acute Kidney Injury Market

28.1. Middle East Acute Kidney Injury Market Overview
28.2. Middle East Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Acute Kidney Injury Market

29.1. Africa Acute Kidney Injury Market Overview
29.2. Africa Acute Kidney Injury Market, Segmentation By Injury, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Acute Kidney Injury Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Acute Kidney Injury Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Acute Kidney Injury Market Competitive Landscape And Company Profiles

30.1. Acute Kidney Injury Market Competitive Landscape
30.2. Acute Kidney Injury Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Acute Kidney Injury Market Other Major And Innovative Companies

31.1. Novartis AG
31.2. Eli Lilly and Company
31.3. Gilead Sciences Inc.
31.4. Amgen Inc.
31.5. Fresenius Medical Care AG & Co. KGaA
31.6. Asahi Kasei Medical Co. Ltd.
31.7. Teva Pharmaceutical Industries Ltd.
31.8. Baxter International Inc.
31.9. B. Braun Melsungen AG
31.10. Nipro Corporation
31.11. Nikkiso Co. Ltd.
31.12. Quark Pharmaceuticals Inc.
31.13. Kringle Pharma Inc.
31.14. Aptabio Therapeutics Inc.
31.15. Alexion Pharmaceuticals Inc.

32. Global Acute Kidney Injury Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Acute Kidney Injury Market

34. Recent Developments In The Acute Kidney Injury Market

35. Acute Kidney Injury Market High Potential Countries, Segments and Strategies

35.1 Acute Kidney Injury Market In 2029 - Countries Offering Most New Opportunities
35.2 Acute Kidney Injury Market In 2029 - Segments Offering Most New Opportunities
35.3 Acute Kidney Injury Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer